Benchmarking antimicrobial use to antimicrobial resistance: a comparative study of two hospitals using current National Healthcare Safety Network (NHSN) metrics
Infection Control & Hospital Epidemiology · 2025
DOI: 10.1017/ice.2024.210 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Infection Control & Hospital Epidemiology, 2025. Verfasst von Carlos A Q Santos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, RUSH University Medical Center, Chicago, IL, USA. Hauptthemen laut MEDLINE: Benchmarking, Antimicrobial Stewardship, Anti-Bacterial Agents, Anti-Infective Agents. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Objective
We aimed to determine whether benchmarking antimicrobial use (AU) to antimicrobial resistance (AR) using select AU/AR ratios is more informative than AU metrics in isolation.
Design
We retrospectively measured AU (antimicrobial therapy days per 1,000 days present) and AU/AR ratios (specific antimicrobial therapy days per corresponding AR event) in two hospitals during 2020 through 2022. We then had antimicrobial stewardship committee members evaluate each AU and corresponding AU/AR value and indicate whether they believed it represented potential overuse, appropriate use, or potential underuse of the antimicrobials, or whether they could not provide an assessment.
Setting
Two acute-care hospitals. Patients: Hospitalized patients.
Results
In semi-annual facility-wide analyses, echinocandins had a median AU/AR ratio of 658.5 therapy days per fluconazole-resistant Candida event in Hospital A, IV vancomycin had a median AU/AR ratio of 114.9 and 108.2 therapy days per methicillin-resistant Staphylococcus aureus event in Hospital A and B, respectively, and linezolid had a median AU/AR ratio of 33.8 and 88.0 therapy days per vancomycin-resistant Enterococcus event in Hospital A and B, respectively. When AU and AU/AR values were evaluated by stewardship committees, more respondents were able to assess antimicrobial use based on AU/AR values compared to AU values. Based on AU/AR ratios, most respondents identified potential overuse of echinocandins and IV vancomycin in Hospital A, and potential overuse of linezolid and IV vancomycin in Hospital B.
Conclusion
Select AU/AR ratios provided informative metrics to antimicrobial stewardship personnel, which can be used to motivate audits of antimicrobial administration to determine appropriateness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Internal Medicine, RUSH University Medical Center, Chicago, IL, USA.
- Department of Pharmacy, RUSH Oak Park Hospital, Oak Park, IL, USA.
- RUSH Digital and Information Services, Chicago, IL, USA.
- Center for Health Equity and Innovation, Cook County Health, Chicago, IL, USA.
- Department of Internal Medicine, RUSH University Medical Center, Chicago, IL, USA.
ORCID-Profile: Carlos A Q Santos, William E Trick
Zitieren
APA
Santos, C. A. Q., Won, S. Y., Dwyer, R., Perez, C., Trick, W. E., & CDC Prevention Epicenters Program (2025). Benchmarking antimicrobial use to antimicrobial resistance: a comparative study of two hospitals using current National Healthcare Safety Network (NHSN) metrics. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2024.210
Vancouver
Santos CAQ, Won SY, Dwyer R, Perez C, Trick WE, CDC Prevention Epicenters Program. Benchmarking antimicrobial use to antimicrobial resistance: a comparative study of two hospitals using current National Healthcare Safety Network (NHSN) metrics. Infection Control & Hospital Epidemiology. 2025. doi:10.1017/ice.2024.210
BibTeX
@article{Santos2025,
author = {Santos, Carlos A Q and Won, Sarah Y and Dwyer, Ryan and Perez, Caren and Trick, William E and CDC Prevention Epicenters Program, CDC Prevention Epicenters Program},
title = {Benchmarking antimicrobial use to antimicrobial resistance: a comparative study of two hospitals using current National Healthcare Safety Network (NHSN) metrics},
journal = {Infection Control & Hospital Epidemiology},
year = {2025},
doi = {10.1017/ice.2024.210}
}
EUVIMED